Managed Account Advisors’s Pediatrix Medical MD Stock Holding History

Managed Account Advisors’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$18.8M	Sell	253,622 -12,997	-5%	-$935K	0.02%	755
2015 Q1	$19.3M	Buy	266,619 +8,977	+3%	+$624K	0.02%	731
2014 Q4	$17M	Sell	257,642 -73,949	-22%	-$4.51M	0.02%	781
2014 Q3	$18.2M	Buy	331,591 +611	+0.2%	+$34.7K	0.02%	725
2014 Q2	$19.2M	Sell	330,980 -43,846	-12%	-$2.58M	0.02%	695
2014 Q1	$23.2M	Buy	374,826 +1,536	+0.4%	+$89.4K	0.03%	604
2013 Q4	$19.9M	Sell	373,290 -21,868	-6%	-$1.17M	0.03%	658
2013 Q3	$19.8M	Buy	395,158 +2,082	+0.5%	+$102K	0.03%	617
2013 Q2	$18M	Buy	+393,076	New	+$17.6M	0.03%	624

Other funds holding MD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CPCM

Clifton Park Capital Management Wilmington, Delaware $881M AUM 5.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Managed Account Advisors's MD Position: Q2 2015 in Review

Managed Account Advisors reduced its Pediatrix Medical (MD) stake by 4.9% in Q2 2015, selling an estimated $935K and leaving 253,622 shares worth $18.8M. The position accounts for 0.02% of the portfolio, ranked #755.

Managed Account Advisors first reported a position in MD in Q2 2013 and has held it in 9 quarters since. The position peaked at $23.2M in Q1 2014. 355 funds tracked by Wall St. Rank hold MD as of Q2 2015.

Managed Account Advisors held 253,622 shares of Pediatrix Medical worth $18.8M as of Q2 2015.
Managed Account Advisors sold 12,997 Pediatrix Medical shares in Q2 2015, an estimated $935K.
Pediatrix Medical made up 0.02% of Managed Account Advisors's portfolio in Q2 2015, its #755 holding.
Managed Account Advisors first reported a position in Pediatrix Medical in Q2 2013 and has held it in 9 quarters since.
Managed Account Advisors's Pediatrix Medical position peaked at $23.2M in Q1 2014.
355 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.